%0 Journal Article
%T Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
%A Ako Hosono
%A Atsushi Manabe
%A Chika Nitani
%A Hide Kaneda
%A Hiroki Yoshihara
%A Junichi Hara
%A Kayoko Shoda
%A Kazuto Nosaka
%A Keigo Saito
%A Kenichi Kohashi
%A Kenichi Yoshimura
%A Manami Shimomura
%A Nobuhiro Tsuchiya
%A Norihiro Fujinami
%A Shoichi Mizuno
%A Tetsuya Nakatsura
%A Toshiaki Yoshikawa
%A Yoshiaki Kinoshita
%A Yosuke Hosoya
%J Archive of "Oncoimmunology".
%D 2018
%R 10.1080/2162402X.2017.1377872
%K peptide vaccine
%K glypican-3 (GPC3)
%K CTL
%K pediatric solid tumors
%K phase I
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739579/